175 related articles for article (PubMed ID: 23119090)
1. Seroprevalence of pertussis in Senegal: a prospective study.
Gaayeb L; Sarr JB; Ndiath MO; Hanon JB; Debrie AS; Seck M; Schacht AM; Remoué F; Hermann E; Riveau G
PLoS One; 2012; 7(10):e48684. PubMed ID: 23119090
[TBL] [Abstract][Full Text] [Related]
2. Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal.
Relyveld E; Oato NH; Guérin N; Coursaget P; Huet M; Gupta RK
Vaccine; 1991 Nov; 9(11):843-50. PubMed ID: 1759508
[TBL] [Abstract][Full Text] [Related]
3. Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphtheria-tetanus-pertussis vaccines in Senegalese infants.
Simondon F; Yam A; Gagnepain JY; Wassilak S; Danve B; Cadoz M
Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):927-32. PubMed ID: 9031875
[TBL] [Abstract][Full Text] [Related]
4. Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia.
Campbell P; McIntyre P; Quinn H; Hueston L; Gilbert GL; McVernon J
PLoS One; 2012; 7(4):e35874. PubMed ID: 22558249
[TBL] [Abstract][Full Text] [Related]
5. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of Bordetella pertussis antibodies to pertussis toxin among healthy children.
Syed MA; Ahmed W; Naeem A; Bokhari H
J Coll Physicians Surg Pak; 2012 Oct; 22(10):677-8. PubMed ID: 23058160
[TBL] [Abstract][Full Text] [Related]
7. Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.
Barug D; Pronk I; van Houten MA; Versteegh FGA; Knol MJ; van de Kassteele J; Berbers GAM; Sanders EAM; Rots NY
Lancet Infect Dis; 2019 Apr; 19(4):392-401. PubMed ID: 30938299
[TBL] [Abstract][Full Text] [Related]
8. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
[TBL] [Abstract][Full Text] [Related]
9. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
10. Anti-pertussis antibody kinetics following DTaP-IPV booster vaccination in Norwegian children 7-8 years of age.
Aase A; Herstad TK; Jørgensen SB; Leegaard TM; Berbers G; Steinbakk M; Aaberge I
Vaccine; 2014 Oct; 32(45):5931-6. PubMed ID: 25218299
[TBL] [Abstract][Full Text] [Related]
11. Differences by sex in IgG levels following infant and childhood vaccinations: An individual participant data meta-analysis of vaccination studies.
Boef AGC; van der Klis FRM; Berbers GAM; Buisman AM; Sanders EAM; Kemmeren JM; van der Ende A; de Melker HE; Rots NY; Knol MJ
Vaccine; 2018 Jan; 36(3):400-407. PubMed ID: 29223483
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination.
Wanlapakorn N; Ngaovithunvong V; Thongmee T; Vichaiwattana P; Vongpunsawad S; Poovorawan Y
PLoS One; 2016; 11(2):e0148338. PubMed ID: 26837004
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age.
Halperin SA; Scheifele D; Barreto L; Pim C; Guasparini R; Medd L; Meekison W; Eastwood BJ
Pediatr Infect Dis J; 1999 Sep; 18(9):772-9. PubMed ID: 10493336
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of diphtheria and pertussis immunoglobulin G among children with pneumonia in Ji'nan, China.
Meng Q; Li L; Shi W; Wang Q; Ding M; Liu Y; Ma X; Yao K
BMC Pediatr; 2018 Dec; 18(1):383. PubMed ID: 30518371
[TBL] [Abstract][Full Text] [Related]
15. Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries.
Berbers G; van Gageldonk P; Kassteele JV; Wiedermann U; Desombere I; Dalby T; Toubiana J; Tsiodras S; Ferencz IP; Mullan K; Griskevicius A; Kolupajeva T; Vestrheim DF; Palminha P; Popovici O; Wehlin L; Kastrin T; Maďarová L; Campbell H; Ködmön C; Bacci S; Barkoff AM; He Q;
Nat Commun; 2021 May; 12(1):2871. PubMed ID: 34001895
[TBL] [Abstract][Full Text] [Related]
16. Combined tetanus-diphtheria and pertussis vaccine during pregnancy: transfer of maternal pertussis antibodies to the newborn.
Vilajeliu A; Goncé A; López M; Costa J; Rocamora L; Ríos J; Teixidó I; Bayas JM;
Vaccine; 2015 Feb; 33(8):1056-62. PubMed ID: 25573035
[TBL] [Abstract][Full Text] [Related]
17. [Serological evaluation of Bordetella pertussis infection in adults with prolonged cough].
Sönmez C; Çöplü N; Gözalan A; Yılmaz Ü; Bilekli S; Demirci NY; Biber Ç; Erdoğan Y; Esen B; Çöplü L
Mikrobiyol Bul; 2016 Jul; 50(3):361-70. PubMed ID: 27525392
[TBL] [Abstract][Full Text] [Related]
18. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
Ladhani SN; Andrews NJ; Southern J; Jones CE; Amirthalingam G; Waight PA; England A; Matheson M; Bai X; Findlow H; Burbidge P; Thalasselis V; Hallis B; Goldblatt D; Borrow R; Heath PT; Miller E
Clin Infect Dis; 2015 Dec; 61(11):1637-44. PubMed ID: 26374816
[TBL] [Abstract][Full Text] [Related]
19. Prospective multinational serosurveillance study of Bordetella pertussis infection among 10- to 18-year-old Asian children and adolescents.
Son S; Thamlikitkul V; Chokephaibulkit K; Perera J; Jayatilleke K; Hsueh PR; Lu CY; Balaji V; Moriuchi H; Nakashima Y; Lu M; Yang Y; Yao K; Kim SH; Song JH; Kim S; Kim MJ; Heininger U; Chiu CH; Kim YJ
Clin Microbiol Infect; 2019 Feb; 25(2):250.e1-250.e7. PubMed ID: 29689428
[TBL] [Abstract][Full Text] [Related]
20. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
